Literature DB >> 21731197

Polymorphisms of CYP1A1, GSTM1 and GSTT1 Loci as the Genetic Predispositions of Oral Cancers and Other Oral Pathologies: Tobacco and Alcohol as Risk Modifiers.

Sumana Chatterjee, Soujatya Dhar, Bani Sengupta, Ashish Ghosh, Manas De, Sumit Roy, Sila Chakrabarti.   

Abstract

Polycyclic aromatic hydrocarbons of tobacco require activation by phase I enzymes, such as cytochrome-P4501A1 (CYP1A1) to become an ultimate carcinogen, which are subjected to detoxification by phase II enzymes, especially glutathione S-transferases (GSTs). A study was designed to find whether genetic predisposition are risk modifiers of oral pathologies. The study included 102 cases with Oral Cancers (OCs), 68 cases with nonmalignant pathologies, 100 cases as control group. GSTM1 null genotype was associated with increased risk of OCs but not with benign pathologies. Deleted GSTT1 was associated with all pathologies. Both m1m2 and m2m2 polymorphisms of CYP1A1 were associated with oral pathologies.

Entities:  

Keywords:  Detoxification; Genotype; Nonmalignant; Oral cancers; Risk modifiers

Year:  2010        PMID: 21731197      PMCID: PMC3001838          DOI: 10.1007/s12291-010-0057-3

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  33 in total

1.  Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene.

Authors:  K Kawajiri; K Nakachi; K Imai; A Yoshii; N Shinoda; J Watanabe
Journal:  FEBS Lett       Date:  1990-04-09       Impact factor: 4.124

Review 2.  Genetic polymorphisms and metabolism of endocrine disruptors in cancer susceptibility.

Authors:  Ana Hatagima
Journal:  Cad Saude Publica       Date:  2002-08-16       Impact factor: 1.632

Review 3.  Oral white lesions with special reference to precancerous and tobacco- related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18-21 1994. International Collaborative Group on Oral White Lesions.

Authors:  T Axéll; J J Pindborg; C J Smith; I van der Waal
Journal:  J Oral Pathol Med       Date:  1996-02       Impact factor: 4.253

4.  Chromosomal changes in betel-associated oral squamous cell carcinomas and their relationship to clinical parameters.

Authors:  Shu Chun Lin; Yann Jang Chen; Shou Yen Kao; Ming Ta Hsu; Chi Hong Lin; Shun Chun Yang; Tsung Yun Liu; Kuo Wei Chang
Journal:  Oral Oncol       Date:  2002-04       Impact factor: 5.337

5.  Ethnic distribution of the glutathione transferase Mu 1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility.

Authors:  H J Lin; C Y Han; D A Bernstein; W Hsiao; B K Lin; S Hardy
Journal:  Carcinogenesis       Date:  1994-05       Impact factor: 4.944

6.  Glutathione S-transferase M3 (A/A) genotype as a risk factor for oral cancer and leukoplakia among Indian tobacco smokers.

Authors:  Nilabja Sikdar; Ranjan Rashmi Paul; Bidyut Roy
Journal:  Int J Cancer       Date:  2004-03       Impact factor: 7.396

7.  Role of tobacco and alcoholic beverages in the etiology of cancer of the oral cavity/oropharynx in Torino, Italy.

Authors:  F Merletti; P Boffetta; G Ciccone; A Mashberg; B Terracini
Journal:  Cancer Res       Date:  1989-09-01       Impact factor: 12.701

8.  Gene deletion of glutathione S-transferase theta: correlation with induced genetic damage and potential role in endogenous mutagenesis.

Authors:  J K Wiencke; S Pemble; B Ketterer; K T Kelsey
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1995 Apr-May       Impact factor: 4.254

9.  The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer.

Authors:  B Ketterer; J M Harris; G Talaska; D J Meyer; S E Pemble; J B Taylor; N P Lang; F F Kadlubar
Journal:  Environ Health Perspect       Date:  1992-11       Impact factor: 9.031

10.  Polymorphisms of selected xenobiotic genes contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population.

Authors:  Abdul K Siraj; Muna Ibrahim; Maha Al-Rasheed; Jehad Abubaker; Rong Bu; Shakaib U Siddiqui; Fouad Al-Dayel; Osama Al-Sanea; Abdulrahman Al-Nuaim; Shahab Uddin; Khawla Al-Kuraya
Journal:  BMC Med Genet       Date:  2008-07-05       Impact factor: 2.103

View more
  4 in total

1.  CYP1A1 polymorphism interactions with smoking status in oral cancer risk: evidence from epidemiological studies.

Authors:  Kai-Tao Yu; Cheng Ge; Xiao-Fang Xu; Jing-Cai Zou; Xuan Zou; Shuai Zhen
Journal:  Tumour Biol       Date:  2014-08-09

2.  CYP1A1 MspI polymorphism and the risk of oral squamous cell carcinoma: Evidence from a meta-analysis.

Authors:  Shang Xie; Chongdai Luo; Xiaofeng Shan; Shushan Zhao; Jing He; Zhigang Cai
Journal:  Mol Clin Oncol       Date:  2016-02-05

3.  Association of CYP1A1 and GSTM1 Polymorphisms With Oral Cancer Susceptibility: A Meta-Analysis.

Authors:  Haitao Liu; Jinlin Jia; Xuemei Mao; Zhiyong Lin
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

4.  Association between the CYP1A1 MspI polymorphism and risk of head and neck cancer: a meta-analysis.

Authors:  Hady Mohammadi; Mehrnoush Momeni Roochi; Farzad Rezaei; Ata Garajei; Hosein Heidar; Bayazid Ghaderi; Masoud Sadeghi
Journal:  Sci Rep       Date:  2022-01-27       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.